| Identification | Back Directory | [Name]
INDEX NAME NOT YET ASSIGNED | [CAS]
2633632-05-8 | [Synonyms]
PROTAC BRD9 Degrader-3
1-{5-[4-({4-[4-(2-butyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)-2-methoxyphenoxy]piperidin-1-yl}methyl)piperidine-1-carbonyl]-2-chlorophenyl}-1,3-diazinane-2,4-dione
2,4(1H,3H)-Pyrimidinedione, 1-[5-[[4-[[4-[4-(2-butyl-1,2-dihydro-1-oxo-2,7-naphthyridin-4-yl)-2-methoxyphenoxy]-1-piperidinyl]methyl]-1-piperidinyl]carbonyl]-2-chlorophenyl]dihydro- | [Molecular Formula]
C41H47ClN6O6 | [MOL File]
2633632-05-8.mol | [Molecular Weight]
755.3 |
| Hazard Information | Back Directory | [Uses]
PROTAC BRD9 Degrader-3 is a BRD9 bifunctional degrader for researching cancer. | [References]
[1] Sabnis RW, et al. BRD9 Bifunctional Degraders for Treating Cancer. ACS Med. Chem. Lett. 2021 Nov 6. |
|
|